Table 4 Clinical events at 2 years.
| All (n = 134) | AMI (n = 103) | |||||||
|---|---|---|---|---|---|---|---|---|
| PR (n = 83) | IR/NR (n = 51) | p Value | PR (n = 68) | IR/NR (n = 35) | p Value | |||
| Death, n (%) | 4 (4.8) | 1 (2.0) | 0.4 | 4 (3.9) | 1 (2.9) | 0.5 | ||
| MI, n (%) | 3 (3.6) | 0 (0) | 0.17 | 2 (2.9) | 0 (0) | 0.3 | ||
| TLR, n (%) | 28 (33.7) | 7 (13.7) | 0.01 | 22 (32.4) | 5 (14.3) | 0.048 | ||
| PCI, n (%) | 26 (92.9) | 6 (85.7) | 20 (90.9) | 4 (80.0) | ||||
| CABG, n (%) | 2 (7.1) | 1 (14.3) | 2 (9.1) | 1 (20.0) | ||||
| Non‐TLR, n (%) | 35 (42.2) | 12 (23.5) | 0.03 | 27 (39.7) | 8 (22.9) | 0.09 | ||
| PCI, n (%) | 33 (94.3) | 11 (91.6) | 25 (92.6) | 7 (87.5) | ||||
| CABG, n (%) | 2 (5.7) | 1 (8.4) | 2 (6.4) | 1 (12.5) | ||||
| Cardiac events, n (%) | 51 (61.4) | 18 (35.3) | 0.003 | 43 (63.2) | 13 (37.1) | 0.01 | ||
AMI, acute myocardial infarction; CABG, coronary artery bypass graft; IR, intermediate remodelling; NR, negative remodelling; PCI, percutaneous coronary intervention; PR, positive remodelling; TLR, target lesion revascularization.